Related Experiment Video
Updated: Jun 16, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Antiphospholipid Antibody Syndrome and Cardiogenic Shock: A Fatal Intersection
Alyssa Naimi1, Mohamed Ramzi Almajed2, Liyan Obeidat1
1Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
Antiphospholipid syndrome (APS) can cause severe cardiac issues, including refractory shock and thrombosis. Prompt, multidisciplinary management, including heart transplantation, is crucial for patients with APS-associated cardiomyopathy.
Area of Science:
- Cardiology
- Rheumatology
- Hematology
Background:
- Cardiac involvement in Antiphospholipid Syndrome (APS) manifests as valvular disease, ventricular dysfunction, and thrombosis.
- Antiphospholipid syndrome (APS) is an autoimmune disorder associated with an increased risk of blood clots.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiopulmonary Resuscitation IV: Pharmacological Management
Rheumatic Heart Disease I: Introduction
Acute Coronary Syndrome I: Introduction
Cardiomyopathy V: Interprofessional Care
